Skip to main navigation Skip to search Skip to main content

Assessment of ALGEL® for endovascular embolization of neurovascular lesions in preparation for clinical trials

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract

The ALGEL material properties that have been optimized through mechanical testing with rheological equipment and biocompatibility testing were analyzed. The ALGEL occlusions were conducted in an in vitro aneurysm model and removed for testing in a rheometer. By altering blood flow through the rete mirabile vessel structure in the skull base of swine, an AVM model was constructed. It was stated that completion of the ALGEL mechanical stability and biocompatibility testing is a prerequisite for the upcoming clinical trail.

Original languageEnglish (US)
Title of host publicationTransactions - 7th World Biomaterials Congress
Pages1521
Number of pages1
StatePublished - 2004
Externally publishedYes
EventTransactions - 7th World Biomaterials Congress - Sydney, Australia
Duration: May 17 2004 → May 21 2004

Publication series

NameTransactions - 7th World Biomaterials Congress

Conference

ConferenceTransactions - 7th World Biomaterials Congress
Country/TerritoryAustralia
CitySydney
Period5/17/04 → 5/21/04

Keywords

  • Alginate
  • Biocompatibility
  • Embolisation

ASJC Scopus subject areas

  • General Engineering

Fingerprint

Dive into the research topics of 'Assessment of ALGEL® for endovascular embolization of neurovascular lesions in preparation for clinical trials'. Together they form a unique fingerprint.

Cite this